Cas:87842-52-2 2-(2-bromoethyl)-2,5,5-trimethyl-1,3-dioxane manufacturer & supplier

Chemical Name:2-(2-bromoethyl)-2,5,5-trimethyl-1,3-dioxane

CAS.NO:87842-52-2

Synonyms:2,5,5-trimethyl-2-(2-bromoethyl)-1,3-dioxane;MFCD00075491;2-(2’bromoethyl)-2,5,5-trimethyl-1,3-dioxane;2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl bromide;4-bromo-2-butanone neopentyl glycol ketal;2,7-DICHLORONAPHTHALENE-1,8-DIAMINE;2-(2-Bromoethyl)-2,5,5-trimethyldioxane

Molecular Formula:C₉H₁₇BrO₂

Molecular Weight:237.13400

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:72-73ºC0.6 mm Hg(lit.)

Density:1.26 g/mL at 25ºC(lit.)

Index of Refraction:n20/D 1.470(lit.)

PSA:18.46000

Exact Mass:236.04100

LogP:2.56060

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,5,5-trimethyl-2-(2-bromoethyl)-1,3-dioxane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-Bromoethyl)-2,5,5-trimethyldioxane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00075491 Use and application,4-bromo-2-butanone neopentyl glycol ketal technical grade,usp/ep/jp grade.

Related News: International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 2-(2-bromoethyl)-2,5,5-trimethyl-1,3-dioxane manufacturer Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. 2-(2-bromoethyl)-2,5,5-trimethyl-1,3-dioxane supplier International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 2-(2-bromoethyl)-2,5,5-trimethyl-1,3-dioxane vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 2-(2-bromoethyl)-2,5,5-trimethyl-1,3-dioxane factory The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.